OsteoStrong

OsteoStrong offers brief, weekly, non-pharmacological sessions using proprietary devices to promote skeletal strength, increase bone density, and improve joint health. The company markets itself as beneficial for all ages and activity levels, especially for those at risk of bone loss. While some clients report improvements in bone density and physical function, particularly in postmenopausal women and those with osteopenia or osteoporosis, independent clinical data supporting its efficacy are limited. The first published clinical trial in 2025 did not show significant improvements in bone mineral density compared to controls.